Observation on the Therapeutic Effect of Shi Qi Wei Da Huo Xue Capsules Combined with Celecoxib in the Treatment of Discogenic Lower Back Pain

Objective: Observing the clinical efficacy of Shi Qi Wei Da Huo Xue Capsules combined with Celecoxib in the treatment of discogenic lower back pain with Qi stagnation and blood stasis syndrome. Methods: Sixty patients with discogenic lower back pain who visited the Orthopedics and Traumatology Department of Wuhu Traditional Chinese Medicine Hospital affiliated with Anhui University of Chinese Medicine from January 2023 to January 2024 were randomly divided into two groups, with 30 in the control group and 30 in the observation group. Patients in the control group were given oral Celecoxib capsules, while the observation group was given a combination of Shi Qi Wei Da Huo Xue Capsules orally. Both groups of patients received a 4-week treatment. Compare the VAS score, ODI score, and total effective rate of two groups of patients before treatment, 2 weeks after treatment, and 4 weeks after treatment. Results: 1) The VAS and ODI scores of both groups decreased at 2 and 4 weeks after treatment compared to before treatment (P<0.05);2) At 2 and 4 weeks after treatment, the VAS and ODI scores in the observation group improved better than those in the control group (P<0.05); 3) The total effective rate of the observation group was 93.33%, which was better than the control group's 86.67% (P<0.05). Conclusion: The combination of Shi Qi Wei Da Huo Xue Capsules and Celecoxib has good clinical efficacy in the treatment of discogenic lower back pain of Qi stagnation and blood stasis type. It can significantly alleviate the symptoms of lower back pain and improve the functional impairment of the patient's lower back.